Европейски съюз - български - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - Антинеопластични средства - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Европейски съюз - български - EMA (European Medicines Agency)

bayer ag - riociguat - Хипертония, белодробна - Антихипертензивни средства за белодробна артериална хипертония - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. Ефективността е демонстрирана в популацията уф включително етиология идиопатична или наследствени или пфу пфу, свързани с болести на съединителната тъкан . paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Европейски съюз - български - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - Лекарства, използвани при диабет - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 и 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Европейски съюз - български - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - Имуносупресори - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Европейски съюз - български - EMA (European Medicines Agency)

vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - Психолептици, хипнотици и успокоителни средства - Кучета - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.

България - български - Изпълнителна агенция по лекарствата

mylan s.a.s. - Левофлоксацин - 500 mg/100 ml solution for infusion

България - български - Изпълнителна агенция по лекарствата

alkaloid-int d.o.o. - Цефподоксим - 100 mg film - coated tablets

Европейски съюз - български - EMA (European Medicines Agency)

ge healthcare as  - регаденозон - Миокардиална перфузия - Сърдечна терапия - Този лекарствен продукт е само за диагностична употреба. Компанията rapiscan е селективен коронарный вазодилататор за използване като фармакологичен стрес-представител радионуклидная визуализация перфузия на миокарда (ВПМ) при възрастни пациенти, които не могат да се подлагат на адекватно физическо натоварване.